Ray Takigiku, Ph.D.
President and CEO
Previously was Director of Discovery Core Technologies, Analytical and Bioanalytical for Procter & Gamble Pharmaceuticals, and also Interim co-Director of the Genome Research Institute (now Metabolic Diseases Institute) of the College of Medicine, University of Cincinnati. Dr. Takigiku has extensive experience in leading and leveraging multifunctional teams for developing and implementing new technologies to discover, develop and provide technical support for pipeline and marketed drugs. He was part of the leadership team behind the blockbuster drug Actonel®. At P&G, Dr. Takigiku worked with global business units inside and outside of healthcare, testing and developing new models of innovation. In addition to being a Director at Bexion, Dr. Takigiku serves on a number of Boards, including Health Source of Ohio. Dr. Takigiku received his undergraduate degrees from the University of Colorado, and Ph.D. from Indiana University.